ArticleArchives of medical science : AMS2026
The anti-lung cancer effect of ethyl acetate extract from Wenxia Formula
Article in Archives of medical science : AMS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Previous research had shown that the ethyl acetate extract from Wenxia Formula (WFEA extract) had significant effects in inhibiting tumor and cancer associated fibroblasts (CAFs). However, the anti-cancer mechanism of the WFEA extract was still unclear. In this study, we aimed to illuminate the possible anti-cancer mechanisms of the WFEA extract. Material and methods: Ultra-performance liquid chromatography quadrupole time-of-flight mass spectrometry (UPLC/Q-TOF-MS) was applied to analyze and identify the constituents of WFEA extract. The lung cancer xenograft model was conducted to explore the antitumor activity of WFEA extract by measuring tumor volume and weight, HE staining, immunohistochemistry, and immunofluorescence assay. Western blot and qRT-PCR were used to measure the expressions of related proteins and genes in the Hedgehog-Gli1 (Hh-Gli1) signaling pathway. Results: A total of 15 chemical constituents were identified in the WFEA extract. The xenograft model showed that WFEA extract could inhibit tumor growth and had no significant effect on body weight of mice. In addition, WFEA extract reduced the expression of a-SMA, FAP and N-cadherin in the CAF mediated lung cancer xenograft model and increased the expression of E-cadherin. Western blot and qRT-PCR showed that WFEA extract reduced the expression of related proteins and genes (Smo, Gli1 and Ptch1) in the Hh-Gli1 signaling pathway. Conclusions: WFEA extract had a certain inhibitory effect on lung cancer, and its mechanism may be related to the CAF mediated Hh-Gli1 signaling pathway.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.